United States (US) Mice Model Market (2025-2031) | Share, Segmentation, Analysis, Outlook, Industry, Forecast, Companies, Trends, Competitive Landscape, Growth, Value, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Mice Model Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Mice Model Market - Industry Life Cycle

3.4 United States (US) Mice Model Market - Porter's Five Forces

3.5 United States (US) Mice Model Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Mice Model Market Revenues & Volume Share, By Specialty, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing demand for personalized medicine and precision therapies, which require the use of mice models for research and development.

4.2.2 Increasing RD activities in pharmaceutical and biotechnology companies, driving the need for mice models in drug discovery.

4.2.3 Rising prevalence of chronic diseases, leading to a higher demand for mice models for disease modeling and drug testing.

4.3 Market Restraints

4.3.1 Ethical concerns related to animal testing, leading to potential regulatory restrictions on the use of mice models.

4.3.2 High cost associated with maintaining and breeding mice models, which can limit adoption among smaller research organizations.

4.3.3 Availability of alternative technologies, such as in vitro models and computational simulations, posing a competitive challenge to the mice model market.

6.1 United States (US) Mice Model Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Mice Model Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Mice Model Market Revenues & Volume, By Transgenic Mice Model, 2021- 2031F

6.1.4 United States (US) Mice Model Market Revenues & Volume, By Hybrid / Congenic Mice Model, 2021- 2031F

6.1.5 United States (US) Mice Model Market Revenues & Volume, By Knockout Mice Model, 2021- 2031F

6.2 United States (US) Mice Model Market, By Specialty

6.2.1 Overview and Analysis

6.2.2 United States (US) Mice Model Market Revenues & Volume, By Immunology, 2021- 2031F

6.2.3 United States (US) Mice Model Market Revenues & Volume, By Central Nervous System, 2021- 2031F

6.2.4 United States (US) Mice Model Market Revenues & Volume, By Oncology, 2021- 2031F

6.2.5 United States (US) Mice Model Market Revenues & Volume, By Cardiovascular, 2021- 2031F

6.2.6 United States (US) Mice Model Market Revenues & Volume, By Diabetes, 2021- 2031F

6.2.7 United States (US) Mice Model Market Revenues & Volume, By Metabolism & Regulation, 2021- 2031F

7.1 United States (US) Mice Model Market Export to Major Countries

7.2 United States (US) Mice Model Market Imports from Major Countries

8.1 Average lifespan of mice models used in research studies, indicating the efficiency and effectiveness of the models in representing human diseases.

8.2 Number of research publications citing the use of mice models in the United States, reflecting the level of adoption and acceptance in the scientific community.

8.3 Investment in mice model research and infrastructure by academic institutions and government agencies, showcasing the commitment to advancing research using mice models.

9.1 United States (US) Mice Model Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Mice Model Market Opportunity Assessment, By Specialty, 2021 & 2031F

10.1 United States (US) Mice Model Market Revenue Share, By Companies, 2024

10.2 United States (US) Mice Model Market Competitive Benchmarking, By Operating and Technical Parameters